Halozyme Therapeutics, Inc. (NASDAQ:HALO) Investor Alert: Investigation over Potential Misleading Statements
An investigation for investors in NASDAQ:HALO shares over potential securities laws violations by Halozyme Therapeutics, Inc. was announced and NASDAQ:HALO stockholders should contact the Shareholders Foundation.
View full press release